As I have said in the past, AMZN is done as far as being a growth stock. Today’s announcement about online pharmaceutical sales is just a distraction. Throughout their history and continuing today they have only one profitable business. AWS was and is their only cash cow, however their once almost total market share and obscene profit margins are and will continue to shrink. They make no money on all their low margin, high volume businesses and prescription drugs with all the competition is just more of the same. As they no longer have the benefit of the huge margins and significant market share from AWS,(still the leader but increasing competitive pressure) they no longer have significant growth prospects to justifty their outrageous valuation. Today’s pop from the latest distraction will fade away shortly and the inevitable decline will continue over the months and years to come.